FDA approves first rapid, at-home COVID-19 self-test

FDA approves first rapid, at-home COVID-19 self-test

WASHINGTON — The U.S. Food and Drug Administration has granted emergency use authorization for the first at-home COVID-19 self-test kit.

The all-in-one test kit, developed by Lucira Health, detects the virus’ genetic material, and can provide results within 30 minutes.

READ: ‘Tired to the bone’: Hospitals overwhelmed with virus cases

Content Continues Below

The tester uses a swab in each nostril five times before the swab is stirred in a sample vial to start the test.

A light-up display on the test unit will say whether it’s negative or positive.

Lucira expects the single-use tests to cost around 50 dollars each.

Some retailers have already been selling at-home tests, but those aren’t FDA approved, and they require the user to send them back for results.

Lucira says their test will at first only be available on a limited basis through healthcare networks that prescribe the test.

They hope to make it more widely available to the public by the spring.

The FDA has also authorized the test for use in doctor’s offices, hospitals, and urgent care centers.